Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Tu

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Blood|August 14, 2013
PARP-1 regulates expression of TGF-β receptors in T cellsPin Zhang, Hiroko Nakatsukasa, Eric Tu, et al.
Nature Immunology|September 1, 2015
The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cellsHiroko Nakatsukasa, Dunfang Zhang, Takashi Maruyama, et al.
JCI Insight|February 8, 2022
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLCEric Tu, Kelly McGlinchey, Jixin Wang, et al.
Journal for Immunotherapy of Cancer|November 17, 2024
Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumorsDiwakar Davar, Benedito A Carneiro, Grace K Dy, et al.
Cancer Research Communications|September 3, 2025
IPH5201, an anti-CD39 monoclonal antibody, as monotherapy or in combination with durvalumab in advanced solid tumorsJohn Powderly, Martina Imbimbo, Antoine Italiano, et al.
The Journal of Clinical Investigation|November 15, 2023
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancerPeter Zanvit, Dewald van Dyk, Christine Fazenbaker, et al.
Journal of Personality and Social Psychology|October 31, 2024
A worldwide test of the predictive validity of ideal partner preference matchingPaul W Eastwick, Jehan Sparks, Eli J Finkel, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Blood|August 14, 2013
PARP-1 regulates expression of TGF-β receptors in T cellsPin Zhang, Hiroko Nakatsukasa, Eric Tu, et al.
Nature Immunology|September 1, 2015
The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cellsHiroko Nakatsukasa, Dunfang Zhang, Takashi Maruyama, et al.
JCI Insight|February 8, 2022
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLCEric Tu, Kelly McGlinchey, Jixin Wang, et al.
Journal for Immunotherapy of Cancer|November 17, 2024
Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumorsDiwakar Davar, Benedito A Carneiro, Grace K Dy, et al.
Cancer Research Communications|September 3, 2025
IPH5201, an anti-CD39 monoclonal antibody, as monotherapy or in combination with durvalumab in advanced solid tumorsJohn Powderly, Martina Imbimbo, Antoine Italiano, et al.
The Journal of Clinical Investigation|November 15, 2023
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancerPeter Zanvit, Dewald van Dyk, Christine Fazenbaker, et al.
Journal of Personality and Social Psychology|October 31, 2024
A worldwide test of the predictive validity of ideal partner preference matchingPaul W Eastwick, Jehan Sparks, Eli J Finkel, et al.
Pageof 3